Article Menu

Export Article

More by Authors Links

Article Data

  • Views 2795
  • Dowloads 157

Original Research

Open Access

The diagnostic value of color Doppler ultrasound on ovarian cancer in nude mice

  • X.W. Wang1,2
  • J.W. Tian1,*,
  • L.L. Fan3
  • R.H. Wang4

1Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin

2Department of Ultrasnography in Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, Harbin

3Department of Children’s and Adolescent Health, Public Health College, Harbin Medical University, Harbin

4Department of General Surgery, Heilongjiang University of Traditional Chinese Medicine, Harbin (China)

DOI: 10.31083/j.ejgo.2020.02.5250 Vol.41,Issue 2,April 2020 pp.273-276

Published: 15 April 2020

*Corresponding Author(s): J.W. Tian E-mail: wxwbwc2015@126.com

PDF (372.21 kB) View Full-text

Abstract

Objective: Color Doppler ultrasound was used to evaluate the intraabdominal ovarian cancer tumor model in nude mice, to explore its diagnostic value on ovarian cancer in nude mice. Materials and Methods: A SKOV3 cell line was utilized to establish intraperitoneal implant tumor model of ovarian cancer in nude mice. The nude mice were divided into five groups,each group received different drugs. Color Doppler ultrasound was used to evaluate the size of intraabdominal tumor and its color Doppler blood flow. And the final pathological results were compared with the results of color Doppler ultrasound. Results: Color Doppler ultrasound can evaluate the change of length diameter (a) and width diameter (b) of tumor tissue over time and the change of echo of tumor tissue in nude mice; the blood supply and vascular resistance index (RI) value detected by color Doppler ultrasound showed no significant difference; the length diameter, width diameter of tumor measured by ruler, and color Doppler ultrasound showed no significant differences (p > 0.05). Conclusion: Color Doppler ultrasound is of important diagnostic value for ovarian cancer in nude mice. And it is the preferred method to evaluate the growth of intraabdominal implantation tumor in nude mice.

Keywords

Color Doppler ultrasound; Nude mice; Ovarian cancer.

Cite and Share

X.w. Wang, J.w. Tian, L.l. Fan, R.h. Wang. The diagnostic value of color Doppler ultrasound on ovarian cancer in nude mice. European Journal of Gynaecological Oncology. 2020; 41(2): 273-276. doi: 10.31083/j.ejgo.2020.02.5250

URL:

https://www.ejgo.net/articles/10.31083/j.ejgo.2020.02.5250

References

[1] Yahata T., Mizoguchi M., Kimura A., Orimo T., Toujima S., Kuninaka Y., et al.: “Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression”. Cancer Sci., 2019, 110, 1279.

[2] Siegel R.L., Miller K.D., Jemal A.: “Cancer statistics, 2016”. CA Cancer J. Clin., 2016, 66, 7.

[3] Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., et al.: “Parkin DM, Forman D, Bray F. Cancer incidence andmortalityworldwide: sources, methods and major patterns inGLOBOCAN 2012”. Int. J. Cancer, 2015, 136, E359.

[4] Doufekas K., Olaitan A.: “Clinical epidemiology of epithelial ovarian cancer in the UK”. Int. J. Womens Health, 2014, 6, 537.

[5] Kobayashi M., Rice G.E., Tapia J., Mitchell M.D., Salomon C.: “Exosomesare fingerprints of originating cells: potential biomarkers for ovarian cancer”. Res. Rep. Biochem., 2015, 5, 101.

[6] Beral V., Hermon C., Peto R., Reeves G., Brinton L., Marchbanks P., et al.: “Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies”. PLoS Med., 2012, 13, 936.

[7] Gong T.T., Wu Q.J., Vogtmann E., Lin B., Wang Y.L.: “Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiologicalstudies”. Int. J. Cancer, 2013, 132, 2894.

[8] Rosen D.G., Yang G., Liu G., Mercado-Uribe I., Chang B., Xiao X., et al.: “Ovarian cancer: pathology, biology, and disease models”. Front. Biosci., 2009, 14, 2089.

[9] Permuth-Wey J., Sellers T.A.: “Epidemiology of ovarian cancer”. Meth. Mol. Biol., 2009, 472, 413.

[10] Cuellar-Partida G., Lu Y., Dixon S.C., Fasching P.A., Hein A., Burghaus S., et al.: “Assessing the genetic architecture of epithelialovarian cancer histological subtypes”. Hum. Genet., 2016, 135, 741.

[11] Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J.: “Cancer statistics”. CA. Cancer J. Clin., 2007, 57, 43.

[12] Romero-Laorden N., Olmos D., Fehm T., Garcia-Donas J., DiazPadilla I.: “Circulating and disseminated tumor cells in ovarian cancer: a systematic review”. Gynecol. Oncol., 2014, 133, 632.

[13] Hua T., Ruijun G., Hongyan Z.: “Misdiagnosis analysis of pelvic mass by color doppler ultrasound”. Chinese Journal of Medical Ultrasound (electronic edition), 2011, 8, 2001. (In Chinese)

[14] Chun D., Yong G., Haiming H., Haiyan X.: “Diagnosticvalue vascular resistance index combined with CA125 for ovarian tumor”. Journal of North Sichuan Medical College, 2017, 32, 788. (In Chinese)

[15] Menon-Andersen D., Mondick J.T., Jayaraman B., Thompson P.A., Blaney S.M., Bernstein M., et al.: “Population pharmacokinetics of imatinibmesylate and its metabolite in children and young adults”.Canc. Chemother. Pharmacol., 2009, 63, 229.

Submission Turnaround Time

Top